Chris Witkowsky

It’s this 'stuck in the middle' cohort that is really the prime example of the challenges of the fundraising market today.

William Blair estimates about $72bn in GP-led activity this year, up from around $50bn last year.

Avance’s first fund hit the market in 2020 just as society shut down in the health crisis, completely changing the way private equity firms had to approach prospective investors.

It’s instructive to see the evolution of the market, including various ways to provide liquidity to investors in older funds, even when some more traditional exit paths are closed.

Around 14% of GP-led market volume in the first half involved growth and venture capital, which was up markedly from the first half last year, according to Lazard’s half-year secondary volume report.

As some portfolio companies have thrived and grown beyond expectations, many firms are looking beyond the traditional public filing for solutions.

Deal attribution is a major factor in helping potential fund investors understand the track record of the founders.

Albert’s departure comes as Patient Square moves through fundraising for its second private equity pool.

Architect is out in the fundraising market that has been battered by slow exit activity and limited partners reluctant to extend themselves outside of their deepest relationships.

When a CV asset goes bankrupt, if the restructuring plan calls for equity to be wiped out to make sure creditors are repaid, that includes CV investors and rolling LPs.